semaglutide after kidney transplant and Transplants: Safety Considerations Semaglutide: A Breakthrough for Chronic

But theyve run into a bit of a dilemma: Many people with these conditions are already underweight, and GLP-1 drugs are just too good at making people lose more weight.

Am J Surg Pathol (2019) 43:133140

For people with or without diabetes, this can sometimes lead to low blood sugar episodes (hypoglycemia), a major cause of dizzinessespecially when you havent eaten or after intense physical activity

doi: 10.1002/14651858.CD003538.PUB2 247 NortonRLHoffmannPR

How This Blind Spot Leads Directly Into the Next Crisis If we cannot explain how GLP-1 agonists exert their multi-system effects, then we cannot reliably determine who benefits from them, why certain responses emerge, or which biological signatures distinguish durable responders from partial responders, early plateauers, non-responders, or individuals at risk for muscle loss, inflammatory rebound, or neuroprotective divergence